N
orovirus is the most common cause of gastroenteritis (1) , and it is estimated to cause Ͼ90% of viral gastroenteritis cases and 50% of all gastroenteritis outbreaks (2) . Annually in the United States, norovirus causes approximately 21 million cases of gastroenteritis (1) and is the most common cause of gastroenteritisrelated emergency department visits (3) . In developing countries, norovirus is estimated to cause an annual 1 million hospitalizations and 200,000 deaths in children below the age of 5 years (2) .
Human noroviruses belong to the family Caliciviridae, genus Norovirus, and contain a positive-sense, single-stranded RNA genome (4, 5) . The genome is approximately 7.7 kb in length and is organized into three open reading frames (ORF). ORF1 encodes the nonstructural proteins, including the RNA-dependent RNA polymerase (RdRp); ORF2 encodes viral protein 1 (VP1), the major capsid protein; and ORF3 encodes VP2, a minor structural protein (6, 7) . The major capsid protein, VP1, is characterized by three structural domains, the shell (S) domain and two protruding (P) domains, P1 and P2 (8) . The P domain is the most exposed region of the capsid protein and is likely to contain the determinants for antigenicity and host cell attachment (8) (9) (10) . The human histo-blood group antigens (HBGA) are host cell attachment factors for norovirus, and the HBGA binding interface of the norovirus P domain has been elucidated through crystallography and mutagenesis studies (11) (12) (13) . Although the residues of the binding interface are fairly conserved among strains within the same genogroup, noroviruses interact with HBGAs in a strain-specific manner (14, 15) .
Based on sequence analysis of regions within the VP1 or RdRp genes, noroviruses are classified into five genogroups, with a sixth genogroup having been proposed (16) . Genogroup I, II, and IV (GI, GII, and GIV, respectively) noroviruses are known to infect humans, but GII noroviruses are the most common. Human noroviruses can be further classified into at least 25 different genotypes (17) . GII.4 is the most common genotype circulating worldwide, having caused at least four global epidemics since 1995, each caused by a distinct GII.4 antigenic variant (18) (19) (20) (21) . Genotype II.3 is a common cause of sporadic infection in children (22) (23) (24) (25) . In infants and young children, GII.3 strains often predominate and were particularly prevalent in various countries throughout the late 1970s and 1980s (22) , the early 1990s (26) (27) (28) , and in the early and late 2000s (25, (29) (30) (31) . Interestingly, most GII.3 noroviruses detected in the 2000s were recombinant strains, possessing a non-GII. 3 RdRp genotype (25, (29) (30) (31) .
Natural recombination is considered a common event between norovirus strains (32) . Recombination occurs most often within or near the ORF1/ORF2 overlap region between the RdRp and capsid genes (intergenic recombination), producing a virus with differing capsid and RdRp genotypes (32) . Recombinant strains have been widely reported in recent years, and a number of novel RdRp genotypes which have no corresponding capsid genotype, such as GII.a and GII.b, have been identified (32) . Recombinant strains are frequently detected in children, particularly strains with a GII.3 capsid gene and GII.b RdRp gene (29, 31, 33, 34) .
Recombination is a major driving force of viral evolution (32) , allowing a substantial exchange of genetic material. However, GII.3 VP1 evolutionary analyses. The six strains for which the complete VP1 sequence was determined in this study had previously been genotyped in the RdRp region through sequence analyses (33) , except for strain 537/547/VP1/2010/AU. Unpublished RdRp sequence data were available for this strain (537/547/VP1/2010/AU) (33) (22) . For these strains and the strains for which the GII.3 VP1 sequences were obtained from GenBank, the RdRp genotype was determined via multiple phylogenetic analyses of corresponding RdRp sequences using MEGA v5 and confirmed using the norovirus genotyping tool (41) . A literature search was conducted to determine the assigned RdRp genotype for strains lacking published RdRp sequence data. For GII.3 VP1 sequences with corresponding published sequence for RdRp region A (274 bp) (n ϭ 28), a phylogenetic tree was prepared (containing an additional seven standard strains) using the maximum likelihood method as available in MEGA v5. The Tamura-Nei (42) model of nucleotide substitution was selected as the most appropriate model for this data set.
GII.3 RdRp data set (n ‫؍‬ 66). The GII.3 RdRp data set comprised all available RdRp region A (274 bp) GII.3 sequences in GenBank (as of June 2012) with collection date information. Region A was chosen as it is a commonly sequenced region for genotyping and thus enabled a larger sample size. The genotype of the capsid gene for strains in this RdRp sequence data set was determined (using the norovirus genotyping tool [41] ) for seven strains, all of which had capsid genotype GII.3. The capsid genotype was unknown for the remaining 59 strains. The HKY (43) model of nucleotide substitution was selected as the most appropriate model for this data set.
GII.b RdRp data set (n ‫؍‬ 110). The GII.b RdRp data set comprised all available region A (274 bp) GII.b sequences from GenBank (as of June 2012) with collection date information. The genotype of the capsid gene for strains in this RdRp sequence data set was determined (using the norovirus genotyping tool [41] ) for 37 of the 110 strains. Where known, the majority of the GII.b RdRps were associated with a GII.3 capsid (22/ 37); however, 5 were each associated with a GII.1 and GII.21 capsid, 3 with a GII.2 capsid, and 2 with a GII.13 capsid. Despite not being associated with a GII.3 capsid, these RdRp sequences were included in the analysis to increase GII.b RdRp sample size. The HKY (43) model of nucleotide substitution was selected as the most appropriate model for this data set.
Evolutionary analyses. Nucleotide substitution models for phylogenetic and evolutionary analyses were selected using the Akaike information corrected criterion (AICc) implemented in JModelTest (44, 45) . Evolutionary analyses, including substitution rate estimation, prediction of the time to most recent common ancestor (tMRCA), and phylogenetic analyses, were conducted using the Bayesian Markov chain Monte Carlo (MCMC) algorithm as available in the Bayesian Evolutionary Analysis by Sampling Trees (BEAST) package, v1.5.4 (46) . All three available molecular clock models were tested, including the strict-clock model and two relaxed-clock models (the uncorrelated exponential deviation [UCED] and uncorrelated log normal deviation [UCLD]). The Bayesian skyline model for population growth was implemented, as no appropriate demographic model for seasonal population growth and decline was available. BEAST analyses were run three times for each clock model until MCMC chain convergence was achieved (estimated sample size, Ͼ200). Tracer v1.5 (http://beast.bio.ed.ac.uk/Tracer) was used to view BEAST output files and to produce Bayesian skyline plots of population growth, and FigTree v1.3.1 (http://tree.bio.ed.ac.uk/) was used to view phylogenetic trees.
Detection of amino acid sites under selection. The HyPhy software package was used to determine site-specific positive and negative selection as rates of nonsynonymous or synonymous change (dN/dS) within the VP1 capsid protein (47) . The data set contained the 72 aligned norovirus GII.3 VP1 sequences with 548 codons. The single-likelihood ancestor counting method (SLAC) was chosen as the most conservative method (48) to detect sites of selection, with a significance level limit of 0.25 (the global dN/dS value was estimated, ambiguities averaged, and a neighborjoining tree used as input). The significance level refers to a cutoff P value for the two-tailed extended binomial test to classify a site as positively or negatively selected.
Homology modeling. The tertiary structure of the capsid protein sequence of strain 693/425/2008/AU was modeled based on solved homologous capsid structures using the I-TASSER online server (49) . Homology models were viewed and edited using PyMoL (PyMOL molecular graphics system, version 1.3; Schrödinger, LLC). A dimer of duplicate capsid monomers was formed based on the Norwalk virus capsid structure (Protein Data Bank [PDB] code 1IHM) using PyMol.
Nucleotide sequence accession numbers. The complete VP1 gene sequences from the six Australian GII.3 strains sequenced for this study were submitted to the GenBank database under accession numbers KC464324 to KC464329.
RESULTS
To explore the evolution of norovirus GII.3 capsid genes and the importance of intergenic recombination, the capsid gene of 6 norovirus GII.3 strains, isolated from Australian children, were sequenced and aligned with 66 GII.3 VP1 sequences from GenBank spanning 1975 to 2010. Evolutionary analyses, including substitution rate estimation, phylogenetic analysis, and selection analysis, were conducted. Additionally, the corresponding RdRp genotypes of each strain used in the GII.3 VP1 evolutionary analyses were also determined to detect evidence of intergenic recombination. Rate analyses were conducted for two common RdRp genotypes associated with the GII.3 capsid to detect differences in RdRp evolutionary rates.
Phylogenetic analysis. Based on the simplest model for Bayesian phylogenetic analysis, the strict clock, VP1 sequences grouped into three major clusters (I, II, and III) that are similar to those defined previously for GII.3 sequences (22) . In this study, the larger clusters were further defined into five smaller lineages (A to E), which were characterized by conserved amino acid substitutions ( Fig. 1 ; also see Table 2 ). Sequences previously classified as cluster I were grouped into lineage A along with the 1983 Goulburn Valley strain (GoulburnValleyG5175A/1983/AU). Sequences in cluster II were split into lineages B and C, and cluster III sequences were divided primarily into lineages D and E. Lineages were generally observed to be temporally sequential, and collection dates of the corresponding strains within each lineage were the following (Fig. 1) . There was also a distinct subcluster within lineage D (subcluster D) which contained strains isolated in Japan, China, and South Korea in the years 2003 to 2010. This group of sequences was defined as a subcluster rather than a lineage, as it emerged from a common ancestor within lineage D. Subcluster D and lineage E evolved simultaneously from 2006 onwards. Given that lineage E contained sequences isolated from Australia, India, and the Netherlands and subcluster D contained sequences isolated solely in Japan, China, and South Korea, it is likely that these two lineages evolved in geographic isolation.
Nine sequences did not group into any lineage and clustered between lineages C and D. These unclustered sequences included sequences from norovirus strains isolated between 1990 and 2001 and one strain collected in 2010.
The VP1 sequences from the six Australian pediatric strains that were sequenced in this study clustered among other international strains in lineages D (isolated before 2006) and E (isolated after 2006). This indicates worldwide circulation of typical GII.3 norovirus strains rather than separate evolution within isolated areas, with the exception of the subcluster D strains.
RdRp genotyping. In order to investigate the incidence and importance of intergenic recombination on the evolution of GII.3 noroviruses, the genotype of the RdRp gene was determined for GII.3 strains used in the VP1 evolutionary analyses. RdRp genotyping information was available for 58 of the 72 strains used in these analyses, including all 4 strains within lineage A, 3 out of 5 strains in lineage B, 9 out of 14 strains in lineage C, 26 out of 30 strains in lineage D, and all 10 strains in lineage E. Of the nine unclustered sequences between lineages C and D, RdRp genotyping information was available for six. The RdRp genotype associated with each capsid sequence is shown in Table 1 .
Although all strains in this analysis had a GII.3 VP1 gene, five different RdRp genotypes were observed: GII.3, GII.12, GII.a, GII.b, and an undefined ancestral RdRp genotype (see Fig. S1 in the supplemental material). The ancestral RdRp was most closely related to a GII.4 RdRp (Hu/GII/Shanghai/SH2/2008/CHN; accession no. GU991353.1), although it only shared 80% nucleotide identity over 777 bp of ORF1 (GoulburnValleyG5175A/1983/ AU). This is low compared to the Ն96% similarity shared by GII.3 RdRps, thus a genotype for these RdRps could not be established. The GII.12 RdRp was also difficult to define, as it has previously been referred to as both GII.12 (31, 52) and GII.4 (32, 53) . For simplicity, in accordance with the Norovirus genotyping tool, this genotype has been labeled GII.12 in this study (41) .
RdRp genotyping was associated with the clustering observed for GII.3 VP1 (Fig. 1 ). All strains with sequences in VP1 lineage A had an ancestral RdRp. This suggests that GII.3 VP1 sequences had an RdRp genotype that predated the GII.3 RdRp. Strains with a GII.3 RdRp genotype did not emerge until 11 years after the emergence of lineage A (ancestral RdRp) strains. Strains in both VP1 lineages B and C had genotype GII.3 RdRps, as did one strain that did not cluster within any lineage (CHDC5261/1990/US). All but one of the remaining VP1 unclustered strains had the recombinant GII.a RdRp, and one, which clustered closely with lineage D, had a recombinant GII.b RdRp (Herzburg385/2001/DE). Strains which clustered into lineages D and E based on capsid sequence also possessed recombinant RdRps. Strains in VP1 lineages D and E were associated with a GII.b RdRp, with the exception of strains in the VP1 subcluster D, all of which were associated with the GII.12 RdRp genotype. Overall, of the 58 strains in the analyses that were typed based on the RdRp gene sequence, the majority (41.38%) possessed a GII.b RdRp, followed by GII.3 (24.41%), GII.12 (24.41%), GII.a (6.89%), and ancestral (6.89%) RdRps. This indicates that the recombinant GII.b RdRp was the most successful RdRp in aiding the evolution of GII.3 viruses; however, these statistics may be biased by the limitation of available sequence data.
Amino acid alignment. To identify amino acid sites of evolutionary importance, the 72 GII.3 capsid protein sequences from 1975 to 2010 were aligned, revealing 167 variable sites (30.47%) and 61 parsimony informative sites. On alignment of parsimony informative sites, major evolutionary patterns were observed which characterized individual lineages by 36 conserved substitutions (Table 2) . A conserved substitution was defined as an amino acid change (compared to a previous lineage) carried by the majority of strains within a lineage. Conserved substitutions which characterized the unclustered strains with a GII.a RdRp were also noted. The conserved substitutions defined a mutational profile for each particular lineage which served to distinguish one lineage from the next. To be conserved within an entire lineage, these amino acids must have been somewhat beneficial to the fitness of the virus. Thus, sites carrying these conserved substitutions may play key roles in interacting with human attachment factors (HBGA) or the immune system. In particular, conserved amino acid substitutions at sites 311, 312, 381, 385, and 415 align with residues of GII.4 predicted antibody binding regions, epitope A and epitope E (9, 10), and all confer a change in charge or polarity. Sites 385, 389, and 404 may be particularly important evolutionary sites, since these sites are highly variable, with three or four different conserved substitutions occurring at these positions throughout the evolution of the capsid protein.
Positive selection. Sites under diversifying or purifying selective pressure were determined based on rates of synonymous and nonsynonymous change. The SLAC test identified five sites that were under positive selective pressure and 288 sites under negative selective pressure at the 0.25 level of significance (P value cutoff, two-tailed extended binomial test). The five amino acid sites predicted to be under positive selection, sites 297, 304, 385, 389, and 406, were all parsimony informative and sites of lineage-specific conserved substitutions, with the exception of site 297. Four of these sites were predicted as sites of positive selection by Boon and colleagues (22) (sites 304, 385, 389, and 406), indicating that these sites are strongly selected regardless of variation in the number of sequences in the analysis.
Protein modeling of sites of conserved substitution. To predict the location of sites of conserved substitution and positive selection on the GII.3 capsid protein, a homology model for the GII.3 capsid protein dimer of strain 693/425/2008/AU was created using the I-TASSER server. Sites of conserved substitution and Where sequences were obtained from GenBank, the accession number is indicated in the taxon label. Strains sequenced for this study are italicized. An asterisk beside the taxon label indicates a strain for which the RdRp genotype was not determined. Previously defined clusters (I to III), new genetic lineages (A to F), and RdRp genotypes are indicated. Major nodes are labeled with the posterior probability that the associated taxa clustered together. Major branches are labeled (in boldface) with the tMRCA for all taxa within the cluster. tMRCA is expressed as the number of years prior to the collection date of the most recent samples included in the tree (2010). The tree is drawn to scale with branch lengths in units of time (years). sites under positive selection were mapped onto the GII.3 capsid dimer three-dimensional structure (Fig. 2) . Most sites, including those under positive selection, were mapped to the protruding domain of the capsid protein. Three sites under positive selection, 304, 385, and 406, were located on the surface of the protruding domain. The remaining sites under positive selection, 297 and 389, were not surface exposed, although changes at these sites may structurally alter important surface-exposed residues. The conserved substitution T289V, which results in a change in polarity and is specific to lineage D and E strains, is located in the P2 domain beside the highly variable site 385. Sites 289 and 385 are adjacent to site 386, which is a region predicted to bind HBGAs (attachment factors) (12) . Additionally, conserved amino acid substitutions occurring at sites 355 (lineage E specific) and 394 were in close proximity to sites 356/357 and 448/449, which are also major residues of the HBGA binding region (12) . Furthermore, the potential antibody binding sites 311, 312, 381 (epitope A), and 415 (epitope E) were all mapped to surface-exposed regions of the P2 domain (9, 10). Capsid gene evolution rates. To estimate the rate of evolution in GII.3 capsid genes from 1975 to 2010, the mean rate of nucleotide substitutions per site per year for the 72 GII.3 capsid gene sequences was measured using a Bayesian MCMC algorithm. The mean rate of substitution was calculated at 4.16 ϫ 10 Ϫ3 , 6.97 ϫ 10 Ϫ3 , and 5.54 ϫ 10 Ϫ3 nucleotide substitutions per site per year based on the strict, UCED, and UCLD molecular clock models, respectively ( Table 3 ). The three clock models determined that the most recent common ancestor of all strains in the data set existed in the early 1970s (Table 3) .
RdRp gene evolution rates. To determine and compare evolution rates conferred by the RdRp proteins of different genotypes, the substitution rates of GII.3 (n ϭ 66) and GII.b (n ϭ 110) RdRp genes (region A) were separately measured using the Bayesian MCMC algorithm. All three clock models were tested for each group. The mean substitution rates and highest probability density (HPD) intervals for the GII.3 and GII.b RdRp genes are shown graphically in Fig. 3 . All clock models predicted that the GII.b RdRp evolved 1.5 to 2 times faster than the GII.3 RdRp. The GII.3 RdRp gene evolved at a nucleotide substitution rate of 2.79 ϫ 10 Ϫ3 , 3.85 ϫ 10 Ϫ3 , and 3.99 ϫ 10 Ϫ3 based on the strict, UCED, and UCLD clock models, respectively, whereas the equivalent clock models predicted the GII.b RdRp gene to have evolved at rates of 5.59 ϫ 10 Ϫ3 , 7.68 ϫ 10 Ϫ3 , and 6.12 ϫ 10 Ϫ3 . The strictclock model had tighter HPD intervals than the two relaxed-clock models and predicted that the GII.b RdRp evolved at a significantly higher rate than the GII.3 RdRp (no overlap of HPD intervals). Due to overlap of the HPD intervals for the two relaxedclock model predictions, the evolution rate differences between the GII.3 and GII.b RdRp genes could not be confirmed as significant; however, the general trend indicates an increased evolution rate conferred by the recombinant GII.b RdRp. Tighter HPD in- tervals could be achieved in the future with analysis of larger samples sizes and/or a larger region of the gene. Relative effective population size over time. Using the Bayesian skyline model of population growth in the BEAST package, the relative effective viral population size over time was measured based on the GII.3 VP1 data set as well as the GII.3 and GII.b RdRp data sets (Fig. 4) . This model predicts the relative effective population size over time (N e ), where changes in effective population size reflect a change in genetic diversity. Based on the GII.3 VP1 gene sequences (Fig. 4A) , a varying population size profile was observed for GII.3 noroviruses. According to the plot, the emergence of each GII.3 VP1 lineage coincided with a temporal peak in population size, with small peaks occurring in the mid-1970s (lineage A) and the late 1980s (lineage B) and larger peaks occurring in the early 1990s (lineage C), early 2000s (lineage D), and mid-2000s (lineage E/subcluster D). A large bottleneck was also evident in the late 1990s (GII.a RdRp strains), and a smaller bottleneck was evident following the major peak in population size associated with the emergence of lineage D. Population diversity is predicted to be better measured using the RdRp gene instead of the VP1 gene (20) ; however, this was not possible for GII.3 noroviruses due to intergenic recombination throughout GII.3 capsid evolution. Nevertheless, to provide an indication of GII.3 population dynamics based on that of the associated RdRp, the population diversities of the GII.3 and GII.b RdRps were measured (Fig. 4B) . As expected, the GII.3 and GII.b RdRps had peaks in relative effective population sizes in the 1990s and 2000s, respectively. They exhibited similar population profiles, with one major peak followed by a steady population decline, although GII.b had an earlier minor peak. While not entirely different, the GII.3 VP1 plot does not closely match those of the RdRps, which suggests that the RdRp plots were biased by the inclusion of GII.3 or GII.b RdRp sequences not solely associated with the GII.3 capsid. However, both the VP1 and the RdRp plots support the increased genetic diversity of GII.3/GII.3 strains in the 1990s and GII.3/GII.b strains in the 2000s.
DISCUSSION
This study aimed to characterize the evolution of GII.3 capsid gene sequences, with particular focus on the impact of intergenic recombination resulting in the acquisition of a new RdRp. From 1975 to 2010, the GII.3 capsid gene evolved via five different lineages (termed A to F), with a subcluster in lineage D representing a possible sixth lineage. Compared to previously published norovirus GII.3 lineages, lineage A fits into cluster I, lineages B and C fit into cluster II, and lineages D and E fit into cluster III (22) . The lineages emerged in a temporally sequential pattern, with the exception of GII.3 VP1 gene sequences isolated after 2006, where two lineages were evolving simultaneously in distinct geographical locations (Fig. 1) .
The branching pattern of GII.3 VP1 capsid gene sequences was shown to be associated with intergenic recombination within the ORF1/ORF2 region. Throughout the evolution of the GII. A single study conducted in the United States on norovirus strains collected in the 1970s showed that norovirus strains possessing a GII.3 VP1 gene and ancestral RdRp gene were the most prevalent genotype circulating in children at that time (22) . Genotype GII.3/GII.3 (capsid/RdRp) noroviruses were prevalent in children globally from the late 1980s to the late 1990s (22, 23, 26, 27) before being succeeded by GII.3/GII.b recombinant strains, which were a major cause of pediatric disease worldwide from 2000 to 2009 (29, 30, 33, 34, 37, 54) . In contrast, GII.3/GII.a recombinant strains were not as prevalent, causing isolated outbreaks and sporadic disease in Australia, Argentina, and Japan during 1998 and 2002 (55) (56) (57) . The recombinant GII.3/GII.12 strain appeared to be restricted to a specific geographic region, including Japan, China, and South Korea, where it was a major cause of pediatric norovirus disease from 2003 to 2009 (24, 31, 53, 58) .
The nucleotide substitution rate (substitutions/site/year) of GII.3 VP1 gene sequences calculated in this study (4.16 ϫ 10 Ϫ3 to 6.97 ϫ 10 Ϫ3 ) was comparable to that previously reported for GII.3 VP1 gene sequences (4.16 ϫ 10 Ϫ3 to 7.39 ϫ 10 Ϫ3 ) as well as rates reported for GII.4 sequences (4.3 ϫ 10 Ϫ3 to 5.6 ϫ 10 Ϫ3 ) (20, 22, 35) . However, over time the GII.3 VP1 gene has evolved under the replicative control of several different RdRp proteins, thus it is unlikely that the VP1 gene has evolved at a steady rate. RdRp switching may have been a mechanism that allowed increased rates of mutation through acquisition of an RdRp with lower fidelity and/or increased replicative ability. This can lead to the generation of large reservoirs of mutants that enable the virus to adapt to changing environments, improving viral fitness under certain selective pressures (59) (60) (61) . To determine whether the nucleotide substitution rate (and thus the underlying mutation rate) was affected by RdRp switching, we compared the substitution rate of two RdRps associated with the GII.3 capsid, the GII.3 RdRp and the most common recombinant RdRp, that of GII.b. Ideally we would analyze the substitution rate of the GII.3 VP1 gene, grouping VP1 sequences based on the RdRp with which they are associated. This could not be achieved, however, due to low sample size. Thus, region A of the RdRp gene was analyzed as a measure of the substitution rate conferred by the RdRp, as Siebenga and colleagues showed that densely sampled short RdRp sequences provide more reliable evolutionary data than fewer longer VP1 sequences (20) . Substitution rate is not a direct measurement of the mutation rate conferred by the RdRp, rather it is a measurement of the underlying mutation rate combined with selective and transmission pressures (62) . Analysis of the substitution rate in the RdRp gene (rather than VP1) may better serve as an indication of the underlying RdRp mutation rate, since the RdRp protein should be less exposed to strong selective pressures (20) . Our analyses indicated that the GII.b RdRp was evolving at a higher rate than the GII.3 RdRp regardless of the clock model used. The increased mutation rate conferred by the recombinant GII.b RdRp probably produced a more fit virus, thus GII.3/GII.b emerged as a prevalent pediatric strain and the GII.3/GII.3 variant is now rarely detected (33) . This may have been the case in the emergence of each new recombinant GII.3 variant.
The theory that RdRp switching leads to a faster mutation rate is supported by our Bayesian skyline plots of relative effective population size over time. The GII.3 VP1 plot of population diversity illustrates a temporal peak in viral population size coinciding with the emergence of each new lineage/subcluster, most of which emerged due to an RdRp switch. The greatest peak in population size was observed following a large bottleneck just prior to 2000, and this peak was likely due to the gain of the GII.b RdRp (Fig.  4A) . Peaks in population size and, accordingly, the emergence of each lineage coincided with an increase in GII.3 prevalence in children (24, 25, 27-30, 33, 53, 54) . Alternatively, the large bottleneck occurring just prior to 2000 coincides with circulation of GII.3 strains with a GII.a RdRp, which were not prevalent (55) (56) (57) . Therefore, despite a relatively small sample size, the Bayesian skyline plot may provide a good indication of epidemic behavior as suggested by Siebenga and colleagues (20) . This indication of epidemic behavior is also evident in the GII.3 and GII.b RdRp Bayesian skyline plots. Although these plots may have included GII.3 and GII.b RdRp sequences not solely associated with a GII.3 capsid, a notable presence of GII.3/GII.3 strains in the 1990s and GII.3/GII.b strains in the 2000s is still evident (Fig. 4B) .
Whether via a faster mutation rate or by other means, with the exception of the geographically isolated GII.3/GII.12 variants, each new recombinant held a selective advantage over the preceding GII.3 strains as demonstrated by the replacement of GII.3 RdRp genetic variants in circulation (22, 54) . This suggests an important role for intergenic recombination in driving the evolution of GII.3 noroviruses.
Intergenic recombination was not the only force driving GII.3 norovirus evolution, with evidence of antigenic drift and selective pressures playing important roles. Selection analyses identified 5 sites under positive selection and 288 sites under negative selection. Four sites under positive selection (sites 304, 385, 389, and 406) had previously been identified in GII.3 capsid protein sequences spanning the years 1975 to 2006, thus they are likely to be major sites of selection at the population level (22) . Although not all are predicted to be under diversifying selection, 36 sites within the GII.3 capsid protein exhibited conserved amino acid substitutions which defined individual lineages and/or different RdRp groups ( Table 2 ). The fixation of these substitutions within a lineage indicates an evolutionary advantage in variation at these sites. The conserved amino acids constituted a mutational profile for each lineage, defining mutations that allowed divergence into a new lineage, which often coincided with an increased GII.3 prevalence. This suggests that the conserved substitutions within each lineage have been important evolutionary changes that led to fitter versions of previous viruses. The conserved substitutions may have allowed increased fitness through changes in the HBGA binding profile or changes to antibody binding epitopes facilitating immune escape.
In particular, site 385, a highly variable amino acid site under positive selection whose substitutions afford changes in charge and polarity, aligned with residues of GII.4 epitope A, suggesting a role in antibody binding (9, 10) . Thus, variability at this site may be due to immune-selective pressures, since a single amino acid change may permit immune escape (63) . Sites of conserved substitution, 311, 312, 381 (epitope A), and 415 (epitope E), also correspond to antibody binding sites described for GII.4 strains (9, 10). These sites exhibited conserved substitutions in lineages B and/or C, with reversion back to residues seen in lineage A in subsequent recombinant lineages. This may have allowed escape from herd immunity in the younger population.
Similarly, many of the identified conserved substitutions possibly were driven by changing interactions with HBGA receptors. A recent study indicated that a severe bottleneck occurs during norovirus transmission, and HBGAs may act as a structural barrier, selecting compatible norovirus variants (64) . Three regions on the capsid which are highly conserved across GII viruses (including GII.3) have been shown to be major binding regions, interacting primarily with the ␣-1,2 fucose (secretor) or the ␣-1,3 fucose (Lewis) saccharides of different HBGAs (11, 12, 65, 66) . Amino acid variation adjacent to these regions may enable noroviruses to bind different HBGAs in a variety of ways (11) . Many of the conserved substitutions identified in this study occurred in close proximity to the HBGA binding regions (Fig. 2) . Specifically, sites 385 and 289 are adjacent to site 386 of binding region II (12) . As mentioned, site 385 is highly variable and is likely to be involved in antibody binding, while site 289 harbors a GII.a/GII.b/ GII.12-specific mutation which results in a polarity change (T289V). The lineage E-specific amino acid substitution S355T and the recycling substitution R394K occur in close conformational proximity to residues of HBGA binding regions I (sites 356/ 357) and III (sites 448/449) (12) (Fig. 2) . Even minor changes at key sites can alter receptor binding (13) , and the identified GII.3 conserved substitutions may have altered the binding properties of the virus over time.
Changes in the saccharide binding properties of GII.3 norovirus VLPs from each of the years 1975, 1976, 1988, 1990, 1991, 1996 Substitutions in the GII.3 capsid protein generally followed a cyclic pattern of reversion back to previously employed amino acids. It is likely that within the sequence space of the GII.3 capsid protein, only certain amino acids are viable at particular sites due to functional constraints. The GII.3 (VP1) genotype, regardless of RdRp, has a strong association with pediatric infection. Young children are less likely to have had a prior infection, and their naive immune system may allow GII.3 noroviruses to continually infect this demographic without accumulation of continual unique changes to the protein sequence (22) . Additionally, the immature gut would most likely exert different evolutionary pressures than those present in the adult gut and possibly present different binding opportunities for norovirus strains, since various receptor expression levels on epithelial cells change during development (68, 69) . Furthermore, commensal bacteria inhabiting the gut vary with age and can play a role in the regulation of expression of fucosylated glycans, such as HBGAs (70, 71) . Taken together, these factors may provide ideal conditions for norovirus GII.3 strains to establish infection and cause disease.
This study was limited by the low numbers of available GII.3 VP1 capsid gene sequences and associated RdRp variant gene sequences. Furthermore, the commonly circulating GII.3 strains may not have been well represented by those present in GenBank, as the sequences present in GenBank may be from novel or unusual norovirus strains. Additionally, GII.3 VP1 sequences could not be obtained for all years of the study period. These limitations highlight the importance of the continued monitoring and characterization of norovirus GII.3 strains causing disease, particularly in children.
In conclusion, this study has shown that norovirus GII.3 strains have evolved at a high rate that, on a molecular level, is comparable to that of GII.4 strains. However, GII.3 evolution is driven by intergenic recombination and the acquisition of new RdRp genotypes. RdRp switching probably allows for increases in evolution rate, and the gain of a new RdRp is often accompanied by an increase in population size and prevalence. Regardless of RdRp genotype, GII.3 strains are consistently more common in children than adults. This may be due to factors relating to the immature gut and the GII.3 capsid protein's pattern of reversion back to previously used amino acids, as novel alterations in the virus capsid are not required to infect naive pediatric hosts. Since the vaccines under development will be implemented for use in high-risk groups, such as children, it is important to understand the mechanisms controlling the evolution of a pediatric-associated norovirus genotype. Continued research into the mechanisms driving the evolution of norovirus strains is important for effective vaccine design.
